ARCHIVES

Tamoxifen Trial Enrolls 19% Of Women Needed, Fisher Reports To NCAB

This article is from The Cancer Letter archive.

Vol. 18 No. 40 | October 16, 1992

Download PDF Visit The Full Archive

Related Articles

RFA On Pathology Training Released

February 1, 1980

Patient Advocacy: Survivorship Programs Win Funds To form Model Programs

December 13, 1996

GPC Biotech’s Satraplatin Fails To Extend Survival In Hormone-Refractory Prostate Cancer.

November 2, 2007

NCI Branch Chiefs, ACCI Join Support For DeVita

June 25, 1981

In Brief: NBCC Wins Grants To Train Breast Cancer Activists In Language, Concepts Of Science

January 13, 1995

Final Issue Of 1984

December 13, 1984